StonvexLoading…
StonvexStonvexStonvexCore line items from DIBS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $89.62M | $88.26M | $84.68M | $96.85M |
Operating Income | $-18.97M | $-26.21M | $-31.03M | $-25.88M |
Net Income | $-13.67M | $-18.63M | $-22.70M | $-22.54M |
EPS (Diluted) | $-0.38 | $-0.49 | $-0.57 | $-0.59 |
Total Assets | $132.11M | $145.76M | $180.81M | $195.80M |
Total Liabilities | $38.53M | $46.45M | $46.53M | $47.77M |
Cash & Equivalents | $22.88M | $25.96M | $37.40M | $153.21M |
Free Cash Flow OCF − CapEx | $-3.20M | $-4.83M | $-15.35M | $-28.01M |
Shares Outstanding | 36.85M | 35.83M | 39.92M | 39.26M |